Bacterial Outer Membrane Vesicles Loaded with Perhexiline Suppress Tumor Development by Regulating Tumor-Associated Macrophages Repolarization in a Synergistic Way

Tumor-associated macrophages (TAMs) promote tumor development and metastasis and are categorized into M1-like macrophages, suppressing tumor cells, and M2-like macrophages. M2-like macrophages, occupying a major role in TAMs, can be repolarized into anti-tumoral phenotypes. In this study, outer membrane vesicles (OMVs) secreted by Escherichia coli Nissle 1917 carry perhexiline (OMV@Perhx) to explore the influence of OMVs and perhexiline on TAM repolarization. OMV@Perhx was internalized by macrophages and regulated the phenotype of TAMs from M2-like to M1-like efficiently to increase the level of tumor suppressor accordingly. Re-polarized macrophages promoted apoptosis and inhibited the mobility of tumor, cells including invasion and migration. The results indicate that OMVs improve the efficacy of perhexiline and also represent a promising natural immunomodulator. Combining OMVs with perhexiline treatments shows powerfully synergistic anti-tumor effects through co-culturing with re-polarized macrophages. This work is promising to exploit the extensive applications of OMVs and chemical drugs, therefore developing a meaningful drug carrier and immunomodulator as well as expanding the purposes of traditional chemical drugs.

[1]  C. Dandara,et al.  The Tumor Microenvironment in Tumorigenesis and Therapy Resistance Revisited , 2023, Cancers.

[2]  Tae Kon Kim,et al.  Adaptive immune resistance at the tumour site: mechanisms and therapeutic opportunities , 2022, Nature Reviews Drug Discovery.

[3]  Yue Zhang,et al.  Tumor-resident intracellular microbiota promotes metastatic colonization in breast cancer , 2022, Cell.

[4]  F. Balkwill,et al.  Harnessing cytokines and chemokines for cancer therapy , 2022, Nature Reviews Clinical Oncology.

[5]  O. Mir,et al.  Modulating tumor-associated macrophages to enhance the efficacy of immune checkpoint inhibitors: A TAM-pting approach. , 2021, Pharmacology & therapeutics.

[6]  Qinjun Chen,et al.  Sequentially Triggered Bacterial Outer Membrane Vesicles for Macrophage Metabolism Modulation and Tumor Metastasis Suppression. , 2021, ACS nano.

[7]  Wen Yin,et al.  Cancer and stem cells , 2021, Experimental biology and medicine.

[8]  J. Joyce,et al.  Therapeutic Targeting of the Tumor Microenvironment. , 2021, Cancer discovery.

[9]  T. Daemen,et al.  Re-polarization of immunosuppressive macrophages to tumor-cytotoxic macrophages by repurposed metabolic drugs , 2021, Oncoimmunology.

[10]  N. Ajami,et al.  Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients , 2020, Science.

[11]  Yujing Li,et al.  Bacterial Outer Membrane Vesicles Presenting Programmed Death 1 for Improved Cancer Immunotherapy via Immune Activation and Checkpoint Inhibition. , 2020, ACS nano.

[12]  Xiaohong Li,et al.  Bacterial ghosts for targeting delivery and subsequent responsive release of ciprofloxacin to destruct intracellular bacteria , 2020 .

[13]  Shuang Wang,et al.  Biomineralized Bacterial Outer Membrane Vesicles Potentiate Safe and Efficient Tumor Microenvironment Reprogramming for Anticancer Therapy , 2020, Advanced materials.

[14]  A. Selman,et al.  Metformin Reduces NGF-Induced Tumour Promoter Effects in Epithelial Ovarian Cancer Cells , 2020, Pharmaceuticals.

[15]  Tianzhi Huang,et al.  Stem cell programs in cancer initiation, progression, and therapy resistance , 2020, Theranostics.

[16]  Yucai Wang,et al.  Bacterial outer membrane vesicles as a platform for biomedical applications: An update. , 2020, Journal of controlled release : official journal of the Controlled Release Society.

[17]  K. Dzobo,et al.  Taking a Full Snapshot of Cancer Biology: Deciphering the Tumor Microenvironment for Effective Cancer Therapy in the Oncology Clinic. , 2020, Omics : a journal of integrative biology.

[18]  Guojun Huang,et al.  Bioengineering Bacterial Vesicle-Coated Polymeric Nanomedicine for Enhanced Cancer Immunotherapy and Metastasis Prevention. , 2019, Nano letters.

[19]  Sejin Oh,et al.  Invariant NKT cells facilitate cytotoxic T-cell activation via direct recognition of CD1d on T cells , 2019, Experimental & Molecular Medicine.

[20]  Brian Ruffell,et al.  Macrophages as regulators of tumour immunity and immunotherapy , 2019, Nature Reviews Immunology.

[21]  D. Wink,et al.  Molecular Mechanisms of Nitric Oxide in Cancer Progression, Signal Transduction, and Metabolism. , 2019, Antioxidants & redox signaling.

[22]  Wen-Chao Liu,et al.  Crosstalk between hepatic tumor cells and macrophages via Wnt/β-catenin signaling promotes M2-like macrophage polarization and reinforces tumor malignant behaviors , 2018, Cell Death & Disease.

[23]  M. Netea,et al.  Metabolic changes in tumor cells and tumor-associated macrophages: A mutual relationship. , 2018, Cancer letters.

[24]  Jiri Bartek,et al.  Alcohol-abuse drug disulfiram targets cancer via p97 segregase adapter NPL4 , 2017, Nature.

[25]  N. E. Thomford,et al.  The Role of Tumor Microenvironment in Chemoresistance: To Survive, Keep Your Enemies Closer , 2017, International journal of molecular sciences.

[26]  Heather H Gustafson,et al.  Progress in tumor-associated macrophage (TAM)-targeted therapeutics. , 2017, Advanced drug delivery reviews.

[27]  J. Boucher,et al.  TLR4/IFNγ pathways induce tumor regression via NOS II-dependent NO and ROS production in murine breast cancer models , 2016, Oncoimmunology.

[28]  F. Ossendorp,et al.  Combinatorial prospects of nano-targeted chemoimmunotherapy. , 2016, Biomaterials.

[29]  M. Kuehn,et al.  Outer-membrane vesicles from Gram-negative bacteria: biogenesis and functions , 2015, Nature Reviews Microbiology.

[30]  Abhishek K. Jha,et al.  Network integration of parallel metabolic and transcriptional data reveals metabolic modules that regulate macrophage polarization. , 2015, Immunity.

[31]  Vipul Gujrati,et al.  Bioengineered bacterial outer membrane vesicles as cell-specific drug-delivery vehicles for cancer therapy. , 2014, ACS nano.

[32]  Ali Khademhosseini,et al.  Biocompatibility of engineered nanoparticles for drug delivery. , 2013, Journal of controlled release : official journal of the Controlled Release Society.

[33]  Reiko Nishihara,et al.  Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival. , 2012, The New England journal of medicine.

[34]  P. De Baetselier,et al.  Tumor-associated macrophages in breast cancer: distinct subsets, distinct functions. , 2011, The International journal of developmental biology.

[35]  Jeffrey W. Pollard,et al.  Macrophage Diversity Enhances Tumor Progression and Metastasis , 2010, Cell.

[36]  J. Karp,et al.  Nanocarriers as an Emerging Platform for Cancer Therapy , 2022 .

[37]  P. Aavitsland,et al.  Safety review: two outer membrane vesicle (OMV) vaccines against systemic Neisseria meningitidis serogroup B disease. , 2007, Vaccine.

[38]  J. Horowitz,et al.  Inhibition of carnitine palmitoyltransferase-1 in rat heart and liver by perhexiline and amiodarone. , 1996, Biochemical pharmacology.

[39]  A. Nissle [Explanations of the significance of colonic dysbacteria & the mechanism of action of E. coli therapy (mutaflor)]. , 1959, Die Medizinische.